On Wednesday, March 25, 2020, the Oregon Board of Pharmacy filed a temporary emergency rule that prohibits the dispensing of chloroquine and hydroxychloroquine for presumptive treatment or prevention of COVID-19 infection to preserve supplies for treatment of malaria, inflammatory conditions, and documented COVID-19 infection in hospitalized patients.

855-007-0085
Prescriptions for Chloroquine and Hydroxychloroquine during COVID-19 Public Health Emergency

(1) Prescription drug orders for chloroquine or hydroxychloroquine may only be dispensed if:

(a) The prescription is a continuation of therapy begun prior to March 8, 2020; or

(b) The prescriber has provided a diagnosis code based on clinical findings for which the medication is medically indicated; or

(c) If written for a COVID-19 diagnosis, the patient is hospitalized with a positive test result for COVID-19 infection.

(2) Dispensing prescriptions for chloroquine or hydroxychloroquine other than as outlined in this rule is prohibited.

(3) This temporary rule is in effect for the duration of the COVID-19 public health emergency or until rescinded.